piribedil has been researched along with Genetic Predisposition in 1 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, R | 1 |
| Li, J | 1 |
| Wu, Y | 1 |
| Liang, S | 1 |
| Xu, L | 1 |
1 trial available for piribedil and Genetic Predisposition
| Article | Year |
|---|---|
Association of Multiple Dopamine D3 Receptor Gene 3'UTR Polymorphisms with Susceptibility to Parkinson's Disease and Clinical Efficacy of Piribedil Therapy.
Topics: 3' Untranslated Regions; Aged; Female; Genetic Predisposition to Disease; Humans; Male; Middle Aged; | 2021 |